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Abstract
Background—Research suggests children with genetic disorders exhibit greater coping skills 
when they are aware of their condition and its heritability. While the experiences parents have at 
diagnosis may influence their decision to disclose the diagnosis to their children, there is little 
research into this communication. The aim of the current study was to examine the relationship 
between the diagnosis experience and the disclosure experience for parents of children with 
intellectual disabilities; with a child affected by 22q11.2 deletion syndrome (22q11DS) compared 
to a group of parents with children affected with other genetic diagnoses, with a similar age of 
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diagnosis (e.g., Fragile X syndrome) and a group where diagnosis generally occurs early (i.e., 
Down syndrome).
Method—The sample comprised 559 parents and caregivers of children with genetic 
developmental disorders, and an online survey was utilised. Items from the questionnaire were 
combined to create variables for diagnosis experience, parental disclosure experience, child’s 
disclosure experience, and parental coping and self-efficacy.
Results—Across all groups parents reported that the diagnosis experience was negative and 
often accompanied by lack of support and appropriate information. Sixty-eight percent of those in 
the 22q11DS and 58.3% in the Similar Conditions groups had disclosed the diagnosis to their 
child, whereas only 32.7% of the Down syndrome group had. Eighty-six percent of the Down 
syndrome group felt they had sufficient information to talk to their child compared to 44.1% of the 
Similar Conditions group and 32.6% of the 22q11DS group. Parents reported disclosing the 
diagnosis to their child because they did not want to create secrets; and that they considered the 
child’s age when disclosing. In the 22q11DS and Similar Conditions groups, a poor diagnosis 
experience was significantly associated with negative parental disclosure experiences. In the 
Similar Conditions group, a poor diagnosis experience was also significantly associated with a 
more negative child disclosure experience.
Conclusions—As expected this study highlights how difficult most parents find the diagnosis 
experience. Importantly, the data indicates that the personal experiences the parents have can have 
a long-term impact on how well they cope with telling their child about the diagnosis. It is 
important for clinicians to consider the long-term ramifications of the diagnosis experience and 
give the parents opportunities; through, for instance, psychoeducation to prepare for telling their 
child about the diagnosis. Further research is warranted to explore what type of information would 
be useful for parents to receive.
Introduction
It can be a shocking and stressful experience for parents to receive the news that their child 
has a multisystem genetic disorder (Hallberg et al. 2010; Metcalfe et al. 2011), and it can be 
similarly difficult for parents to decide if and what to tell the child about the diagnosis. 
Research suggests that children with genetic disorders exhibit greater coping skills when 
they are aware of their condition and its heritability (Hughes et al. 2002; Mcconkie-Rosell et 
al. 2009; Metcalfe et al. 2011; Tercyak et al. 2002). Despite this positive finding, many 
parents choose not to disclose to their children or to only partially disclose (Gallo et al. 
2005; Metcalfe et al. 2008). Although the communication experiences around the disorder 
potentially have a large impact on family functioning (Rolland, 1994), there is little research 
into the communication of genetic conditions, both from professionals to parents 
(“diagnosis”), and from parent to child (“disclosure”). The absence of advice regarding 
disclosure is particularly problematic when intellectual functioning is affected, as different 
approaches may be needed for parents to effectively communicate the diagnostic 
information to their children (Faux et al. 2012).
One such genetic disorder is 22q11.2 deletion syndrome (22q11DS; also known as velo-
cardio-facial syndrome), which occurs in approximately 1:4000 live births making it one of 
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the most common microdeletion syndromes (Wilson et al. 1994). The syndrome is 
associated with characteristic facial features, congenital heart defects, and abnormalities of 
the palate (McDonald-McGinn et al. 1999). The behavioural phenotype is characterised by 
executive dysfunction (Bish et al. 2005), attention deficits (Niklasson, 2005), social 
impairments (Shashi et al. 2012), autism spectrum disorder features (Fine et al. 2005), and 
anxiety disorders (Fung et al. 2010) and there is a significantly increased risk of mood 
(Green et al. 2009) and psychotic disorders compared to the general population (Murphy et 
al. 1999). Other features of the disorder can include increased risk of infection (Jawad et al. 
2001), neonatal hypocalcaemia (Kitsiou-Tzeli et al. 2005), and recurrent otitis media (Dyce 
et al. 2002). People with 22q11DS often have a borderline intellectual functioning or mild to 
moderate intellectual disabilities; however the majority have the intellectual capacity to 
understand the implications of their genetic condition (Faux et al. 2012). Despite 22q11DS 
being one of the more common genetic developmental disorders, the diagnosis is often 
delayed until later childhood or adulthood as the level of awareness of the syndrome is low 
amongst professionals. 22q11DS can be difficult to recognise due to large inter- and intra-
familial symptomatic variability (Shprintzen, 2008), with some people having few or even 
none of the more well-known features (such as cardiac or palatal anomalies) of the 
syndrome but nonetheless having the deletion
Anecdotally, many parents of children with 22q11DS report a traumatic experience around 
the time of diagnosis (e.g., Hallberg et al. 2010) and this may in turn have an impact on if, 
how and when parents choose to divulge the diagnosis to the child (Forrest et al. 2003). A 
diagnosis can provide relief and comfort for parents in terms of origin of symptoms, 
treatment and prognosis, despite the sorrow and grief about their child’s 22q11DS (Costain 
et al. 2011; Hallberg et al. 2010). Even though putting a name and/or origin to the symptoms 
can be a relief, the experience of receiving a diagnosis can be distressing. Parents of children 
with various conditions (including 22q11DS) have identified the need for adequate and 
understandable information from health professionals (Baird et al. 2000; Green & Murton 
1996; Hallberg et al. 2010). Qualitative research findings on genetic disorders and cancer in 
children suggest that when parents have a more negative diagnosis experience, the 
communication around the syndrome and/or the decision to inform the child is negatively 
influenced; however, this is yet to be quantitatively supported (Hallberg et al. 2010; Young 
et al. 2003).
People typically choose to disclose a genetic disorder to their children because they feel an 
obligation, the child has shown interest in their condition, to explain medical interventions 
or to ensure the child does not feel shame (Faux et al. 2012; Gallo et al. 2005; Hughes et al. 
2002; Metcalfe et al. 2008). From research pertaining to various genetic conditions, it 
appears that full disclosure is typically associated with more adaptive parental coping skills 
including an open communication style and a focus on problem-solving (Metcalfe et al. 
2011; Tercyak et al. 2001). Non-disclosure can occur in 22q11DS because parents feel 
unclear on how and what to tell their child (Faux et al. 2012). Hence, parents have identified 
the need for professional advice regarding developmentally appropriate methods of 
disclosing (Faux et al. 2012; Metcalfe et al. 2011). Although advice from professionals may 
help parents cope emotionally (Metcalfe et al. 2008), Gallo et al. (2005) reported that 80% 
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of parents to children with various disorders received no professional advice regarding the 
method of disclosure.
The purpose of the current study was to investigate the diagnosis and disclosure experiences 
in families where a child has 22q11DS. In order to elucidate these experiences, parents of 
children with 22q11DS were compared to parents of children with other genetic 
developmental disorders with similarly complex phenotypes and characteristics (‘Similar 
Conditions’), such as impaired cognition, life-long symptoms and delayed diagnoses (i.e., 
Tuberous Sclerosis, Williams, Prader-Willi, Fragile X syndromes), as well as a group of 
parents of children with Down syndrome where the diagnosis tends to happen earlier. In 
addition, Down syndrome is distinguished from these other syndromes due to its relatively 
high incidence, strong awareness, and well-recognised characteristic facial features.
It was predicted parents who disclosed would have had a more positive diagnosis experience 
compared to those who did not disclose. It was also hypothesised that the diagnosis and 
disclosure experiences would be more positive for the Down syndrome group, as health 
professionals are well educated in this condition and can provide more information. The 
nature of the relationship between the parental diagnosis experience and disclosure 
experience for both parents and children was examined for each of these groups. It was 
expected that a positive diagnosis experience would result in a more positive disclosure 
experience for both the parent and the child. Finally, it was predicted that self-efficacy and 




The sample comprised 559 parents and caregivers (subsequently referred to as “caregiver 
respondents”) of children with genetic neurodevelopmental conditions (22q11DS N = 193, 
Down syndrome N = 122, Fragile X syndrome N = 34, Williams syndrome N = 48, 
Tuberous Sclerosis N = 111, and Prader-Willi syndrome N = 51). Participants were required 
to be 18 years or older, have an adequate English reading level, and be a parent or caregiver 
to at least one child with one of the aforementioned conditions.
Measures
Due to a lack of published questionnaires investigating diagnosis and disclosure 
experiences, the authors created a survey based on a review of the literature, qualitative 
interviews with family members, and clinical experience. The survey also contained items 
from questionnaires such as the “STIGMA Shout Survey” (Corry 2008), “Inventory of 
parent’s experiences” (Crnic et al. 1981), the “Coping Inventory for Stressful Situations - 
Adult” (Endler & Parker 1990), and the “Being A Parent – Mother” questionnaires 
(Johnston & Mash 1989). The questionnaire contained a mixture of restricted questions 
(multiple choice), quantitative rating scales and open-ended qualitative questions. The 
survey was piloted with a sample from the target population in Australia and Israel prior to 
full-scale administration to ensure that the questions were relevant, appropriately worded 
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and that the questionnaire was not too long. Subsequently, the survey was modified to 
accommodate the changes recommended (e.g., removing and/or rewording questions).
The resulting survey contained 109 items. For the purpose of the current study items from 
the questionnaire were combined in order to create grouping variables for diagnosis 
experience (e.g., “How would you rate the amount and quality of information from the 
health professional about the syndrome at the time of diagnosis”; 1 = Satisfactory, 7 = 
Unsatisfactory), parental disclosure experience (e.g., “How prepared did you feel to have 
the conversation about the diagnosis with your child?”; 1 = Unprepared, 7 = Well prepared), 
child’s disclosure experience (e.g., “Did your child show feelings of distress as a result of 
talking about the diagnosis?”; 1 = Very distressed, 7 = No distress), and parental coping and 
self-efficacy (e.g., “I meet my own personal expectations for expertise in caring for my 
child”; 1 = Strongly disagree, 7 = Strongly agree) for each caregiver respondent. Therefore, 
higher scores for the parental disclosure experience, child’s disclosure experience, and 
parental coping and self-efficacy indicate a more positive experience. However, for the 
diagnosis experience, higher scores mean a more negative experience. An additional 
variable was created for disclosure decision; that is “have you told your child about the 
diagnosis?” with response options of yes or no.
In order to test the psychometric properties of these composite variables, internal 
consistency was examined through item-to-total correlations (minimum criterion = .5 [Hair 
et al. 1998]) and inter-item correlations (minimum criterion = .3 [Hair et al. 1998]). Then, 
principal components analysis confirmed if the items constituted one underlying construct 
(unidimensionality assumed when only one component had an eigenvalue >1, with all 
loadings > .5 [Hair et al. 1998]). The constructs were examined for reliability using 
Coefficient Cronbach’s alpha (acceptable α = .60 [Hair et al. 1998]). All composite 
variables met these criteria with the exception of child’s disclosure experience, where 
reliability was poor (α = .484).
Procedure
To overcome small sample sizes and to maximize response rates a web-based approach was 
utilised. A website was created that contained information on the objectives of the research 
and hyperlinks to the questionnaire (hosted through the online survey software, Zoomerang 
[www.zoomerang.com]), where potential participants could read the information statement 
and begin the questionnaire. The study website link and a brief blurb were posted on 
Facebook pages, newsletters, blogs, and websites for neurodevelopmental disorders. Of the 
99 groups and pages contacted, 39 agreed to advertise the study, 2 actively declined and 58 
did not respond. The blurb and link were posted at regular intervals to ensure they remained 
visible and accessible. In addition, forty (7.16%) of the participants were recruited through 
clinics in Clinical Genetics, in order to get a sample more representative of the population. 
The survey was conducted with the understanding and consent of the participants, and 
received ethical approval from the University of Newcastle’s Human Research Ethics 
Committee.
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Differences between caregiver respondents who disclosed and those who did not disclose 
were compared through a Multivariate Analysis of Variance (MANOVA), with factors 
identified throughout the literature as affecting the choice (i.e., diagnosis experience, 
parental coping and self-efficacy, condition type, and child’s age) as dependent variables 
and disclosure decision as the independent variable. To examine whether the diagnosis 
experience and disclosure experiences (for parent and child) differed between 22q11DS, 
Similar Conditions, and Down syndrome, a series of one-way Analysis of Variances 
(ANOVAs) were conducted with condition type as the independent variable and each of 
diagnosis experience, parental disclosure experience, child disclosure experience, and 
parental coping and self-efficacy as dependent variables. The relationship between the 
parental diagnosis experience and disclosure experiences was tested through correlations for 
each condition. A mediation model was proposed to examine the hypothesis that self-
efficacy and coping skills would mediate the relationship between the diagnosis experience 
and the disclosure experience.
Relevant statistical assumptions were tested and found to be acceptable. However, 
significant levels of skewness were identified across several variables such as parental 
coping and self-efficacy for both 22q11DS and Similar Conditions groups. Due to the large 
sample size (i.e., 559 participants), parametric tests were utilised. However to ensure 
accuracy, confirmatory non-parametric tests were used to ensure the reliability of the 
statistical analysis. An alpha value of .05 was used in all analyses. There was missing data 
from the variables diagnosis experience, parental disclosure experience, child disclosure 
experience, and parental coping and self-efficacy (6.62%, 11.63%, 10.2%, and 15.74% 
respectively). A listwise deletion approach was taken, as it appeared to be missing at 
random. However, caution must be taken when interpreting the results because data may be 
missing for reasons the researchers are unaware of.
Results
Participant demographics (see table 1)
The vast majority of caregiver respondents across all groups were female (22q11DS: 91 %, 
Down syndrome: 93.1%, Similar Conditions: 90.7%) and were married or in a de facto 
relationship (22q11DS: 83.2%, Down syndrome: 85.4%, Similar Conditions: 85.6%). 
Around half of the respondents were living in North America, had completed at least an 
undergraduate university degree, and reported an average income. Commonly, children with 
Down syndrome were diagnosed between birth and six months (80.4%) or prenatally 
(18.8%). Many of those with 22q11DS and Similar Conditions were also diagnosed at birth 
to 6 months of age (36.8% & 36.8% respectively), however a fair proportion were not 
diagnosed until 2 – 5 years (24.3% & 27.3% respectively), and the remainder not until even 
later in life (35.7% & 36%, respectively). Over a quarter of the caregiver respondents in the 
22q11DS group were alone at the diagnosis, and 41.4% were with a partner. The remaining 
respondents were with the child; or the child plus family members, friends, or relatives. 
However, in the Down syndrome group, almost 50% of participants were with a partner at 
diagnosis and only 17.9% were alone. The remainder in this group were with the child 
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and/or family members, friends, or relatives. Medians for the diagnosis experience of 4 - 6 
were recorded for 22q11DS and Down syndrome groups, and 5 - 7 for the Similar 
Conditions group on the relevant, individual Likert scale items (1 = positive, 7 = negative).
Contingency table analyses were conducted to establish whether there was a significant 
relationship between condition type and each of gender, marital status, education level, and 
income. No significant relationships were found. Chi squared analyses demonstrated a 
significant relationship between (a) age at diagnosis and condition type, χ2 (DF = 14, n = 
539) = 183.58, p < .001, with the Down syndrome group overrepresented in the prenatal to 6 
months period and underrepresented in the 7 – 24 months, 2 – 5 years, and 6 - 10 years age 
groups. The 22q11DS group was underrepresented in the prenatal and overrepresented in 6 
to 10 year age groups. The Similar Conditions group was underrepresented in the birth to 6 
months and overrepresented in the 7 – 24 months and 2 - 5 years age groups, (b) disclosure 
decision and condition type, χ2 (DF = 2, n = 510) = 34.32, p < .001, with the Down 
syndrome group overrepresented in non-disclosure and underrepresented in the disclosure 
group; this was reversed in the 22q11DS group, (c) country of residence and condition type, 
χ2 (DF = 8, n = 556) = 45.37, p < .001, with the 22q11DS group overrepresented in Israel 
and underrepresented in North America; and the Down syndrome group underrepresented in 
Israel, and (d) age of the child at disclosure and condition type, χ2 (DF = 8, n = 245) = 
28.05, p < .001, with the 22q11DS group overrepresented in the 16 years or older group and 
the Down syndrome group overrepresented in feeling that the child has always known of 
their diagnosis. That is, although they had told of or discussed the child’s Down syndrome 
with them, they felt there was no specific age of disclosure.
The majority of caregiver respondents in the 22q11DS and Similar Conditions groups had 
disclosed the diagnosis to their child (68% and 58.3% respectively). However, 67.3% of the 
Down syndrome group had not disclosed. Commonly, caregiver respondents disclosed 
because they did not want to create secrets and did not disclose when they felt their child 
was too young. Largely, caregiver respondents in the 22q11DS and Similar Conditions 
groups disclosed when the child was 5-10 years of age, yet many parents in the Down 
syndrome group felt there was no specific disclosure age, the child had always known 
(40%). Eighty-six percent of the Down syndrome group felt they had sufficient information 
to talk to their child compared to only 44.1% of the Similar Conditions group and 32.6% of 
the 22q11DS group. Over 50% of caregiver respondents in the Similar Conditions group had 
not been given advice about disclosure, nor had 35% of those in the 22q11DS group and 
13.3% in the Down syndrome group. The child’s disclosure experience, as rated by the 
caregiver respondents, was generally positive for all condition types, with Likert scale 
medians for the individual questions ranging from 5 – 6 for 22q11DS and Similar 
Conditions groups, and 6 – 7 for the Down syndrome group (1 = negative experience, 7 = 
positive experience). Parental coping and self-efficacy questions had medians ranging from 
4 – 6 in the 22q11DS groups, 5 – 7 in the Down syndrome group, and 4 – 7 in the Similar 
Conditions group on the relevant Likert scales; where 1 = poor coping and self-efficacy, 7 = 
good coping and self-efficacy.
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To examine potential factors affecting the disclosure decision across all conditions, a 
between subjects MANOVA was conducted with disclosure decision (yes or no) as the 
independent variable and four dependent variables (i.e., diagnosis experience, parental 
coping and self-efficacy, condition type, and child’s age [divided into age groups where 1 = 
0 – 2 years, 2 = 3 – 5 years, 3 = 6 – 12 years, 4 = 13 – 17 years, 5 = 18+ years]), see table 2. 
With the use of Pillai’s criterion, the combined dependent variables were significantly 
related to disclosure decision, F(4, 421) = 53.88, p<.001. Univariate analysis found that the 
mean child’s age group for participants who had disclosed (M = 3.66, SD = 1.09) was 
significantly higher than for those who had not disclosed (M = 2.06, SD = 1.18). No other 
significant results were identified.
Then, a series of one-way ANOVAs were performed to investigate differences between the 
three condition type groups in terms of diagnosis experience, disclosure experiences 
(parental and child’s), and parental coping and self-efficacy, see table 2. They revealed that 
there was no significant effect for condition type in terms of diagnosis experience (F [2, 
519] = 1.68, p = .187). However, the Down syndrome group (M = 24.13, SD = 3.40) 
displayed significantly more positive parental disclosure experiences than both 22q11DS (M 
= 19.49, SD = 4.75) and Similar Conditions (M = 20.75, SD =5.14) groups (F [2, 219] = 
8.85, p < .001). Caregiver respondents in the Down syndrome group (M = 11.88, SD = 1.90) 
also had more positive child disclosure experiences than both 22q11DS (M = 10.39, SD = 
2.30) and Similar Conditions (M = 10.43, SD = 5.14) groups (F [2, 224] = 4.34, p = .014). 
However, due to the unequal group sizes (i.e., fewer caregiver respondents in the Down 
syndrome group had disclosed compared to those in the 22q11DS and Similar Conditions 
groups), the results must be interpreted with caution. Finally, the Down syndrome group (M 
= 40.41, SD = 6.20) had higher mean coping and self-efficacy than caregiver respondents in 
the Similar Conditions (M = 38.31, SD = 6.39) group (F [2, 468] = 4.17, p = .016).
Finally, to examine the nature of the relationships (if any) between the diagnosis experience 
and disclosure experiences for parent and child, correlations were carried out. A small 
negative correlation was found between diagnosis experience and parental disclosure 
experience for the 22q11DS group, r = −.221, p = .038 and the Similar Conditions group, r = 
−.313, p = .001; see table 3. That is, (due to the scaling of the survey items) caregiver 
respondents who had a more negative experience around the diagnosis also had a negative 
experience at disclosure; however, this relationship only accounted for about 7% to 8% of 
the variance. No significant correlation was found between the diagnosis experience and the 
child’s disclosure experience in the 22q11DS group r = .028, p = .79. However, a small 
negative correlation was found between the diagnosis experience of the caregiver respondent 
and the child’s disclosure experience for the Similar Conditions group r = −.216, p = .023; 
again, accounting for only about 5% of the variance. There was no significant correlation 
between diagnosis experience of 22q11DS or Similar Conditions and the potential mediator 
of parental coping and self-efficacy (r = −-.091, p = .252 and r = −.063, p = .368 
respectively) hence the mediation model was not conducted. No significant correlation was 
found between diagnosis experience and parental disclosure experience or child’s disclosure 
experience for the Down syndrome group (r = .16, p = .444; r = .06, p = .78; see table 3).
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We investigated the parental experience of having a child diagnosed with a genetic 
developmental disability and if the parental experience affected their decision to disclose the 
diagnosis to the child. Across conditions, most caregiver respondents rated the experience of 
being told the diagnosis as negative. That is, based on the questions in the diagnosis 
experience scale; they found it stressful, felt extremely worried, felt they initially had a poor 
understanding of the syndrome, and the amount and quality of information they received 
from health professionals was unsatisfactory. Caregiver respondents in the Down syndrome 
group disclosed to their child earlier and felt more prepared to do so than 22q11DS and 
Similar Conditions groups. However, close to 70% of caregiver respondents in the Down 
syndrome group had not disclosed, and thus it is possible that many children with Down 
syndrome may grow up knowing of their condition without an official disclosure. 
Alternatively, the timely diagnosis may allow for the caregiver respondents who disclosed to 
adjust and reflect whilst still disclosing relatively early in the child’s life. Further research 
with a greater proportion of disclosing caregiver respondents is required.
Contrary to expectations, across all caregiver respondents the diagnosis experience did not 
differ between those who did and did not disclose, nor was there any significant differences 
in coping and self-efficacy skills or condition type between those who did and did not 
disclose. A potential explanation for this effect is that regardless of the type or time of 
diagnosis, the caregiver respondents found the situation equally traumatic due to the 
challenges their child would face. This is not to say the diagnosis should be avoided. The 
importance of a diagnosis must be recognised, as parents have also reported positive 
outcomes, such as relief, as a result of the news (e.g., Costain et al. 2011; Hallberg et al. 
2010). Rather, the focus should be on reducing the impact of potentially distressing news by 
meeting caregivers’ needs. The diagnosis experience is often perceived as more positive if 
the knowledge is provided in a calm, supportive manner and with a partner or close friend 
present (Baird et al. 2000; Green & Murton 1996). Further, when a diagnosis is provided 
genetic counsellors can facilitate the process of gathering a support network, by referring 
caregivers to relevant local and online support groups; of which there are many for each 
condition type investigated in this study. In the case of a 22q11DS diagnosis, health services 
can provide and explain the international clinical practice guidelines for 22q11DS to parents 
(Bassett et al. 2011).
As expected, the Down syndrome group had more positive parental and child disclosure 
experiences compared to both 22q11DS and Similar Conditions; since Down syndrome is 
well known compared to the other disorders included in the study. Interestingly, the majority 
of the caregiver respondents of children with Down syndrome had not disclosed to their 
child (whereas the opposite was true in both 22q11DS and Similar Conditions groups). The 
current age of children who had been disclosed to was significantly higher than those who 
had not been told. This is somewhat expected as caregiver respondents of 22q11DS children 
have identified concerns about the language to use when disclosing (Faux et al. 2012), 
which may abate as the child grows. Research on various genetic conditions has 
demonstrated that parents believe non-disclosure is emotionally protective; due to fears of 
causing anxiety, inferiority and changed self-perception in their child (Claes et al. 2003; 
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Forrest et al. 2003; Gallo et al. 2005; Hughes et al. 2002; Mcconkie-Rosell et al. 2009; 
Metcalfe et al. 2008; Tercyak et al. 2002). Despite these concerns, there is little empirical 
evidence that emotional damage eventuates as a result of disclosure. Rather, children who 
know about their genetic diagnosis often show improved emotional resilience (Metcalfe et 
al. 2011). Although evidence is lacking for children with 22q11DS, in families with open 
communication, children with genetic disorders exhibit increased coping skills, improved 
attitude to their condition, fewer psychosocial issues and reduced stress levels (e.g., 
Metcalfe et al. 2011; Plumridge et al. 2011). Indeed, qualitative accounts have shown that 
non-disclosure creates secrecy that negatively impacts family cohesion, causing children to 
feel stressed, frustrated, resentful, and anxious (Claflin & Barbarin 1991; Metcalfe et al. 
2008; Plumridge et al. 2011). A positive disclosure experience for children occurs when 
children are informed about their diagnosis in a timely manner, taking cognitive 
development into account, with the opportunity for continued discussion (Faux et al. 2012; 
Metcalfe et al. 2011; Plumridge et al. 2011).
Unexpectedly, there was no relationship between the diagnosis experience and parental or 
child disclosure for the Down syndrome group, perhaps due to the comparatively small 
number of disclosing caregiver respondents. Participants’ strong coping and self-efficacy 
skills may have also prevented the diagnosis experience from affecting disclosure. However, 
as predicted, there was a relationship between the diagnosis experience and parental 
disclosure for each of 22q11DS and Similar Conditions groups. There was also a 
relationship between the diagnosis experience and the child’s disclosure experience for the 
Similar Conditions group only. Contrary to predictions, these relationships were not 
mediated by parental coping. Although qualitatively identified in the choice to disclose, 
diagnosis experience may not be a particularly significant factor in the disclosure decision 
for the wider population. Also, the literature used to guide the predictions was based on 
conditions with different prognoses and implications. Further, there may be factors with an 
influence on disclosure decision that were not examined in the study, such as familial 
relationships, thus there is a need for on-going scientific examination.
The current study had a number of limitations; in particular the study’s web-based approach 
did not allow an investigation of the sample’s representativeness of the wider population. An 
ascertainment bias may restrict the findings since the participants were primarily sourced 
through online support groups. Members of support groups often actively seek information 
and may have received advice from others on disclosure. The biased sampling was also 
demonstrated through the high levels of self-efficacy and coping exhibited by the caregiver 
respondents. Despite these limitations, the web-based approach was chosen to allow 
international accessibility, flexibility for participants, and to improve on the small sample 
sizes found in previous research. A small proportion of participants (N = 40) were also 
recruited through genetic clinics in order to reduce the impact of these sampling issues. The 
sample was predominantly female and thus the results may be biased towards a female 
perspective. Another limitation is that the child’s response to disclosure was based on their 
parent’s perception of the situation. However, similar research has shown continuity 
between parent and child responses (Costain et al. 2011). Also, it is possible the study 
attracted people who had strong feelings about the subject, perhaps due to their own 
diagnosis or disclosure experiences. This issue may have contributed to the lack of findings 
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for the planned mediation analyses. Further, a small proportion of caregiver respondents 
from the 22q11DS and Similar Conditions groups may have been affected by the disorder 
themselves. This could impact their expectations of a diagnosis for their child, how they 
reacted to the diagnosis, and whether they chose to disclose. To some extent it may explain 
the large proportion of disclosing parents in both these groups, as compared to the Down 
syndrome group. An exclusive examination of diagnosis and disclosure experiences when 
the parent has been diagnosed with the same condition is an avenue for future research. The 
use of retrospective self-report data also may have affected participants’ answers; however, 
research has shown that parents tend to remember these experiences accurately (e.g., Carr 
1988). A final limitation that should be considered is our measurement tool. We 
endeavoured to explore the scale’s initial psychometric properties; yet some of the findings 
may have been influenced by unknown measurement error or rater biases. While we feel 
confident in our findings, we are sensitive to the issue that the rating scale may have 
influenced our findings.
Conclusions
This is the first known study to quantitatively investigate the relationship between diagnosis 
and disclosure experiences. As the child’s age was the only significant examined factor in 
the disclosure decision, it would be advantageous to determine other variables that may 
impact the decision to disclose, such as life events, sibling relations, child’s temperament, 
and other key family variables (e.g., socioeconomic status, family size). Also, separate 
analysis for each Similar Condition could increase understanding of the effect condition type 
has on diagnosis and disclosure experiences.
From a clinical perspective, the current research has implications for medical professionals 
and genetic counsellors, such as meeting parents’ informational and emotional needs at 
diagnosis, as well as throughout changes in the child’s developmental stages. Further, if 
future research identifies variables that influence the disclosure decision, such as parental 
coping and self-efficacy, it may provide a foundation for parental training. It is important to 
examine the factors affecting the disclosure decision as communication patterns are related 
to the family’s resilience (e.g., Mcconkie-Rosell et al. 2009). The diagnosis experience 
remains a distressing event for many parents and caregivers and thus is worthy of inclusion 
in future research. Genetic testing and receiving a diagnosis should not be avoided; rather, 
health professionals need to be aware of the impact their diagnosis can have on the parent’s 
and thus the family’s emotional wellbeing.
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22q11DS Down syndrome Similar Conditions
N N N
Female 171 (91%) 108 (93.1%) 225 (90.7%)
Total N 188 116 248
Married/de
facto
158 (83.2%) 99 (85.4%) 214 (85.6%)
Total N 190 116 250
Living in North
America
82 (42.7%) 68 (58.6%) 154 (62.1%)






87 (46%) 58 (50%) 127 (51.6%)
Total N 189 116 246
Reported an
average income
81 (44.3%) 48 (42.9%) 103 (43.6%)
Total N 183 112 236
Diagnosis
experience*
  With partner 77 (41.4%) 55 (49.1%) 89 (36.8%)
  Alone 50 (26.9%) 20 (17.9%) 51 (21.1%)
Total N 186 112 242
Child’s age at
diagnosis
  Prenatal 3 (1.6%) 21 (18.8%) 12 (5%)
  Birth – 6 mo 68 (36.8%) 90 (80.4%) 90 (36.8%)
  7 mo - < 2 yrs 22 (11.9%) 1 (0.9%) 59 (24.4%)
  2 – 5 yrs 43 (24.3%) 0 (0%) 66 (27.3%)
  6 – > 18 46 (24.9%) 0 (0%) 15 (6.2%)
Total N 185 112 242
Note. Similar Conditions includes Tuberous Sclerosis, Williams syndrome, Fragile X syndrome, and Prader-Willi syndrome
*
Remainder of caregiver respondents were with family members, relatives, friends, and/or the child.
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Table 2
MANOVA and ANOVA results for Disclosure decision and (a) Diagnosis Experience, (b) Parental coping and 
self-efficacy, (c) Condition type, and (d) Child's age
MANOVA Disclosure Decision Mean Std. Deviation N F Sig.
Diagnosis
experience
Yes 19.16 a 5.90 237 0.26 .872






Yes 39.11 a 5.40 237 1.179 .278
No 38.46 a 7.04 189
Yes 2.10 a .94 237 1.997 .158
No 2.22 a .78 189
Child’s age
group
Yes 3.66a 1.10 237 210.392 <.001
No 2.06b 1.18 189
ANOVA Condition Type Mean Std. Deviation N F Sig.
Diagnosis
Experience
22q11DS a 19.58 5.67 178 1.680 .187
Down syndrome a 18.27 6.05 107




22q11DS a 19.49 4.75 91 8.845 <.001
Down syndrome b 24.13 3.40 24




22q11DS a 10.39 2.30 93 4.337 .014
Down syndrome b 11.88 1.90 26




22q11DSa,b 38.63 5.49 166 4.173 .016
Down syndrome b 40.41 6.20 97
Similar Conditions a 38.32 6.39 208
Note. Means in the same cell that do not share the same subscripts are significantly different, p<.01.
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Table 3
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